Combination Immunotherapy Promising in Pancreatic Cancer
According to a recent publication in Nature Communications, the combination of an Immune Checkpoint Blocker, a Cancer Vaccine and an Antibody Treatment prior to pancreatic cancer resection surgery. The median overall survival of treated participants showed an improvement over other study arms, which utilized an individual immunotherapy agents rather than the combination approach.
Search our Directory
AABRM Members are not only experts in regenerative medicine but offer a wide range of related products, services and related-procedures in that field. Search our extensive Member Directory to find a Member near you.Member Directory